A review of published cases of PRES secondary to anti-VEGF agents found that it occurred more commonly in female patients, and that proteinuria—another adverse effect of anti-VEGF therapy—was present whenever tested for [23]. Here, VEGFA is linked to Posterior Leukoencephalopathy Syndrome.